JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated

Pabitra Basnyat1, Elina Virtanen2, Irina Elovaara3,4

  • 1Neuroimmunology Unit, School of Medicine, University of Tampere, Tampere, Finland. pabitra.basnyat@uta.fi.

Journal of Neurovirology
|August 24, 2017
PubMed

Insights

JC polyomavirus (JCPyV) microRNAs (miRNAs) in plasma may indicate reactivation in multiple sclerosis (MS) patients treated with natalizumab (NTZ). Lower 5p miRNA levels correlate with higher JCPyV antibody index, suggesting potential for PML risk assessment.

Area of Science:

  • Neuroimmunology
  • Virology
  • Biomarker Discovery

Background:

  • Natalizumab (NTZ) treatment for multiple sclerosis (MS) carries a risk of progressive multifocal leukoencephalopathy (PML).
  • Current JC polyomavirus (JCPyV) serology-based risk stratification has limitations in reducing PML incidence.
  • Sensitive biomarkers are crucial for managing NTZ-associated PML risk.

Purpose of the Study:

  • To evaluate the presence and prevalence of JCPyV microRNAs (miRNAs) in plasma of NTZ-treated MS patients.
  • To explore the potential of JCPyV miRNAs as biomarkers for NTZ-associated PML risk.
  • To investigate the relationship between JCPyV miRNA expression and JCPyV antibody index.

Main Methods:

  • Analysis of plasma samples from NTZ-treated MS patients, interferon-beta (IFN-β)-treated MS patients, and healthy controls (HCs).
  • Quantification of jcv-miR-J1-5p (5p miRNA) and jcv-miR-J1-3p (3p miRNA) expression.
  • Correlation analysis between 5p miRNA levels and anti-JCPyV antibody index.

Main Results:

  • The 5p miRNA was detected in 84% of NTZ-treated patients, 75% of IFN-β-treated patients, and 92% of HCs.
  • Relative 5p miRNA expression was lower in NTZ-treated patients compared to IFN-β-treated patients (p=0.027).
  • A significant inverse correlation was observed between 5p miRNA expression and anti-JCPyV antibody index in JCPyV seropositive NTZ-treated patients (r=-0.756; p=0.002).

Conclusions:

  • JCPyV miRNAs in plasma may be associated with JCPyV reactivation and enhanced viral replication in NTZ-treated MS patients.
  • These findings suggest a potential role for JCPyV miRNAs in assessing PML risk.
  • Further studies with larger datasets, including PML patients, are needed to confirm clinical relevance and predictive potential.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
7.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K